loader
Please Wait
Applying Filters...

Others: Recce Pharmaceuticals Announces Positive Safety Data from Fourth Cohort of Phase I Clinical Trial Evaluating Healthy Subjects Intravenously Dosed with RECCE® 327 - Recce Pharmaceuticals

Xls
Menu